Jean-pierre Bizzari - Net Worth and Insider Trading

Jean-pierre Bizzari Net Worth

The estimated net worth of Jean-pierre Bizzari is at least $3 Million dollars as of 2024-11-13. Jean-pierre Bizzari is the Director of Halozyme Therapeutics Inc and owns about 52,544 shares of Halozyme Therapeutics Inc (HALO) stock worth over $3 Million. Jean-pierre Bizzari is also the Director of ADC Therapeutics SA and owns about 79,502 shares of ADC Therapeutics SA (ADCT) stock worth over $232,941. Details can be seen in Jean-pierre Bizzari's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jean-pierre Bizzari has not made any transactions after 2024-06-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jean-pierre Bizzari

To

Jean-pierre Bizzari Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jean-pierre Bizzari owns 4 companies in total, including Halozyme Therapeutics Inc (HALO) , Pieris Pharmaceuticals Inc (PIRS) , and Celator Pharmaceuticals Inc (CPXX) among others .

Click here to see the complete history of Jean-pierre Bizzari’s form 4 insider trades.

Insider Ownership Summary of Jean-pierre Bizzari

Ticker Comapny Transaction Date Type of Owner
HALO Halozyme Therapeutics Inc 2021-08-25 director
PIRS Pieris Pharmaceuticals Inc 2016-02-16 director
CPXX Celator Pharmaceuticals Inc 2016-07-12 director
LIMIT LIMIT 2023-08-23 director

Jean-pierre Bizzari Latest Holdings Summary

Jean-pierre Bizzari currently owns a total of 2 stocks. Among these stocks, Jean-pierre Bizzari owns 52,544 shares of Halozyme Therapeutics Inc (HALO) as of August 25, 2021, with a value of $3 Million and a weighting of 93.08%. Jean-pierre Bizzari also owns 79,502 shares of ADC Therapeutics SA (ADCT) as of June 17, 2024, with a value of $232,941 and a weighting of 6.92%.

Latest Holdings of Jean-pierre Bizzari

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HALO Halozyme Therapeutics Inc 2021-08-25 52,544 59.64 3,133,724
ADCT ADC Therapeutics SA 2024-06-17 79,502 2.93 232,941

Holding Weightings of Jean-pierre Bizzari


Jean-pierre Bizzari Form 4 Trading Tracker

According to the SEC Form 4 filings, Jean-pierre Bizzari has made a total of 1 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 35,000 shares on August 25, 2021, which brought Jean-pierre Bizzari around $1 Million.

According to the SEC Form 4 filings, Jean-pierre Bizzari has made a total of 1 transactions in ADC Therapeutics SA (ADCT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in ADC Therapeutics SA is the sale of 6,995 shares on June 17, 2024, which brought Jean-pierre Bizzari around $20,216.

Insider Trading History of Jean-pierre Bizzari

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jean-pierre Bizzari Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jean-pierre Bizzari Ownership Network

Ownership Network List of Jean-pierre Bizzari

No Data

Ownership Network Relation of Jean-pierre Bizzari

Insider Network Chart

Jean-pierre Bizzari Owned Company Details

What does Halozyme Therapeutics Inc do?

Who are the key executives at Halozyme Therapeutics Inc?

Jean-pierre Bizzari is the director of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .

Halozyme Therapeutics Inc (HALO) Insider Trades Summary

Over the past 18 months, Jean-pierre Bizzari made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 280,000 shares made by Michael J. Labarre , a net sale of 200,000 shares made by Helen Torley , and a net sale of 49,881 shares made by Matthew L. Posard .

In summary, during the past 3 months, insiders sold 199,881 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 199,881 shares. During the past 18 months, 584,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,881 shares.

Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Halozyme Therapeutics Inc Insider Transactions

No Available Data

Jean-pierre Bizzari Mailing Address

Above is the net worth, insider trading, and ownership report for Jean-pierre Bizzari. You might contact Jean-pierre Bizzari via mailing address: 235 Laurel Ln, Haverfold Pa 19041.